83 International, expanded-access programme of everolimus in patients with metastatic renal cell carcinoma who progressed after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: Sub-analysis of European patients
S. Bracarda, S. Rottey, A. Bahl, C. Eichelberg, B. Mellado, L. Mangel, J. Mardiak, I. Bouzaklas, A. Panneerselvam, V. GrünwaldVolume:
11
Year:
2012
Language:
english
DOI:
10.1016/s1569-9056(12)60082-7
File:
PDF, 35 KB
english, 2012